Madrigal Pharmaceuticals, Inc. (MDGL)

Last Closing Price: 379.10 (2026-11-20)

Income after Taxes (Quarterly)

Income after Taxes: Earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.

Madrigal Pharmaceuticals, Inc. (MDGL) had Income after Taxes of $55.44M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$431.27M
$55.44M
$37.81M
$393.45M
$375.28M
$55.99M
$-0.55M
$55.44M
$55.44M
Income after Taxes
$55.44M
$55.44M
$55.44M
$55.44M
$55.99M
$57.72M
29.25M
30.31M
$1.90
$1.83
Balance Sheet Financials
$1.39B
$13.96M
$47.28M
$1.43B
$454.24M
$341.27M
$353.20M
$807.45M
$626.94M
$619.85M
$626.94M
23.22M
Cash Flow Statement Financials
$-23.55M
$320.18M
$15.41M
$203.78M
$515.45M
$311.66M
$108.34M
--
--
Fundamental Metrics & Ratios
3.05
--
--
0.35
0.54
91.23%
12.98%
12.98%
--
12.86%
12.86%
$-35.58M
--
--
--
0.30
0.31
1.90
47.45
8.84%
8.94%
3.87%
5.73%
$27.00
$-1.17
$-0.78